Prosure® Orange flavor 380g
Prosure® Orange flavor 380g
REBUILD, RESUME AND STRENGTHEN TO FIGHT CANCER
IMPORTED FROM SPAIN
Maltodextrin, calcium caseinate, sucrose, marine oil, fructo-oligosaccharides, MINERALS (magnesium sulfate, sodium phosphate, sodium chloride, potassium citrate, calcium carbonate, sodium sulfate, potassium chloride, zinc sulfate, manganese sulfate, copper sulfate, chromium chloride, sodium molybdate, potassium iodide, sodium selenate), arabic gum, VEGETABLE OILS (fractionated coconut (MCT) oil, soybean oil, high oleic sunflower oil), whey protein hydrolysate, emulsifier and stabilizer (soy lecithin), VITAMINS (ascorbic acid, choline chloride, antioxidant (ascorbyl palmitate), Vitamin E, antioxidant (mixed tocopherols), niacinamide, calcium-d-panthothenate, Vitamin D3, Vitamin B12, Vitamin A, beta carotene, biotin, folic acid, pyridoxine hydrochloride, thiamine hydrochloride, riboflavin, Vitamin K1) soy polysaccharide, flavoring, taurine and I-carnitine.
Contains milk, soy and fish ingredients.
Examining guidelines and new evidence in oncology nutrition
Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognised and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes.
The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 read this short article to learn more about the benefits of HMB.
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
This opinion article, published in Journal of American Medical Directors Association (JAMDA), addresses the role of muscle mass in improving health outcomes in a variety of disease states. It also offers strategies you can use to help patients manage low muscle mass and prevent muscle loss.
Footnotes:
*When consuming two servings per day of ProSure as part of a comprehensive cancer-care program. Clinical studies conducted in weight-losing cancer patients, including pancreatic, lung, head & neck, leukemia, colorectal and esophageal cancer.
References:
HKG.2025.58198.AND.1
SESSION TIMEOUT
You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.
You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.
Stay Connected